{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:02:11Z","timestamp":1725602531068},"publisher-location":"Boston, MA","reference-count":85,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461368519"},{"type":"electronic","value":"9781461541295"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997]]},"DOI":"10.1007\/978-1-4615-4129-5_7","type":"book-chapter","created":{"date-parts":[[2011,8,24]],"date-time":"2011-08-24T19:16:13Z","timestamp":1314213373000},"page":"87-103","source":"Crossref","is-referenced-by-count":0,"title":["High-dose chemotherapy in non-Hodgkin\u2019s lymphoma"],"prefix":"10.1007","author":[{"given":"Jean-Yves","family":"Blay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry O.","family":"Philip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"7_CR1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1200\/JCO.1994.12.1.226","volume":"12","author":"B Coiffier","year":"1994","unstructured":"Coiffier B, Philip T, Burnett AK, Symann M (1994). Consensus conference on Intensive Chemotherapy plus Hematopoietic Stem Cell Transplantation in Malignancies, June 4-6, 1994. Lyon, France. J Clin Oncol 12:226\u2013231.","journal-title":"J Clin Oncol"},{"key":"7_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/oxfordjournals.annonc.a058678","volume":"5","author":"B Coiffier","year":"1994","unstructured":"Coiffier B, Philip T, Burnett AK, Symann M (1994). Consensus conference on Intensive Chemotherapy plus Hematopoietic Stem Cell Transplantation in Malignancies, June 4-6, 1994. Lyon, France. Ann Oncol 5:19\u201323.","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"7_CR3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/annonc\/5.suppl_1.S19","volume":"5","author":"DD Weisenburger","year":"1994","unstructured":"Weisenburger DD (1994). Epidemiology of non Hodgkin\u2019s lymphoma: recent findings regarding an emerging epidemic. Ann Oncol 5(Suppl 1):S19\u2013S24.","journal-title":"Ann Oncol"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","volume":"328","author":"RL Fisher","year":"1993","unstructured":"Fisher RL, Gaynor ER, Dahlberg S, et al. (1993). Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non Hodgkin\u2019s lymphoma. N Engl J Med 328:1002\u20131006.","journal-title":"N Engl J Med"},{"key":"7_CR5","first-page":"S23","volume":"Suppl 2","author":"SJ Horning","year":"1993","unstructured":"Horning SJ (1993). Low-grade lymphoma 1993: state of the art. Ann Oncol (Suppl 2):S23\u2013S27.","journal-title":"Ann Oncol"},{"key":"7_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.1987.5.2.197","volume":"5","author":"CA Coltman","year":"1987","unstructured":"Coltman CA, Dahlberg S, Jones SE, et al. (1987). CHOP is curative in thirty percent of patients with large cell lymphomas: a twelve-year Southwest Oncology Group follow-up. Proc Am Soc Clin Oncol 5:197 (abstract).","journal-title":"Proc Am Soc Clin Oncol"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-102-5-596","volume":"102","author":"P Klimo","year":"1985","unstructured":"Klimo P, Connors JM (1985). MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann Intern Med 102:596\u2013602.","journal-title":"Ann Intern Med"},{"key":"7_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1200\/JCO.1983.1.2.91","volume":"1","author":"AT Skarin","year":"1983","unstructured":"Skarin AT, Canellos GP, Rosenthal DS, et al. (1983). Improved prognosis of diffuse histiocytic and undifferenciated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol 1:91\u201396.","journal-title":"J Clin Oncol"},{"key":"7_CR9","first-page":"444a","volume":"82","author":"B Coiffier","year":"1993","unstructured":"Coiffier B, Tilly H, Bosly A, Sebban C, Herbrecht R, Gisselbrecht (1993). Long term follow-up of the 737 aggressive lymphoma patients treated with the LNH84 protocol: very few relapses after 5 years. Blood 82:444a (abstract).","journal-title":"Blood"},{"key":"7_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.V52.1.85.85","volume":"52","author":"FR Appelbaum","year":"1978","unstructured":"Appelbaum FR, Herzig GP, Ziegler JL, et al. (1978). Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 52:85\u201395.","journal-title":"Blood"},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.1983.1.7.440","volume":"1","author":"FR Appelbaum","year":"1983","unstructured":"Appelbaum FR, Thomas ED (1983). Review of the use of marrow transplantation in the treatment of non Hodgkin\u2019s lymphoma. J Clin Oncol 1:440\u2013447.","journal-title":"J Clin Oncol"},{"key":"7_CR12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1200\/JCO.1988.6.8.1303","volume":"6","author":"SC Gulati","year":"1988","unstructured":"Gulati SC, Shank B, Black L, et al. (1988). Autologous bone marrow transplantation for patients with poor prognosis lymphoma. J Clin Oncol 6:1303\u20131313.","journal-title":"J Clin Oncol"},{"key":"7_CR13","first-page":"274","volume":"10","author":"AM Gianni","year":"1991","unstructured":"Gianni AM, Bregni M, Siena S, et al. (1991). Prospective randomized comparison of MACOP-B vs rGM-CSF supported high dose sequential myeloablative chemotherapy in diffuse large cell lymphoma. Proc Am Soc Clin Oncol 10:274 (abstract).","journal-title":"Proc Am Soc Clin Oncol"},{"key":"7_CR14","first-page":"87a","volume":"82","author":"C Haioun","year":"1993","unstructured":"Haioun C, Lepage E, Gisselbrecht C, et al. (1993). Comparison of autologous bone marrow transplantation with sequential chemotherapy for aggressive non Hodgkin\u2019s lymphoma (NHL) in first complete remission: a study on 464 patients (LNH87 protocol). Blood 82:87a (abstract).","journal-title":"Blood"},{"issue":"Suppl 1","key":"7_CR15","first-page":"157","volume":"80","author":"S Tura","year":"1992","unstructured":"Tura S, Zinzani PL, Mazza P, et al. (1992). ABMT vs DHAP in residual disease following third generation regimens for agressive non Hodgkin\u2019s lymphoma. Blood 80(Suppl 1):157 (abstract).","journal-title":"Blood"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0002-9343(77)90230-3","volume":"63","author":"R Fisher","year":"1977","unstructured":"Fisher R, DeVita VT, Johnson BL, Simon R, Young RC (1977). Prognostic factors for response and survival in adults with advanced non Hodgkin\u2019s lymphoma. Am J Med 63:177\u2013180.","journal-title":"Am J Med"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/archinte.1978.03630270051019","volume":"138","author":"F Cabanillas","year":"1978","unstructured":"Cabanillas F, Burke JS, Smith TL, Moon ME, Butler JJ, Rodriguez V (1978). Factors predicting for response and survival in adults with advanced non Hodgkin\u2019s lymphoma. Arch Intern Med 138:413\u2013417.","journal-title":"Arch Intern Med"},{"key":"7_CR18","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1200\/JCO.1989.7.10.1518","volume":"7","author":"F Swan Jr","year":"1989","unstructured":"Swan F Jr, Velasquez WS, Tucker S, et al. (1989). A new serologic staging system for large cell lymphomas based on initial \u03b22 microglobulin and lactate dehydrogenase levels. J Clin Oncol 7:1518\u20131527.","journal-title":"J Clin Oncol"},{"key":"7_CR19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1200\/JCO.1991.9.2.211","volume":"9","author":"B Coiffier","year":"1991","unstructured":"Coiffier B, Gisselbrecht C, Vose JM, et al. (1991). Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d\u2019Etude des lymphomes Agressifs. J Clin Oncol 9:211\u2013219.","journal-title":"J Clin Oncol"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"MA Shipp","year":"1993","unstructured":"Shipp MA, Harrington DP, Anderson JR, et al. (1993). A predictive model for aggressive NHL: the International Non Hodgkin\u2019s Lymphoma Prognostic Factor Project. N Engl J Med 329:987\u2013992.","journal-title":"N Engl J Med"},{"key":"7_CR21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-98-3-304","volume":"93","author":"RI Fischer","year":"1983","unstructured":"Fischer RI, DeVita VT, Hubbard SM, et al. (1983). Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy. Ann Intern Med 93:304\u2013309.","journal-title":"Ann Intern Med"},{"key":"7_CR22","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.1988.6.7.1118","volume":"6","author":"T Philip","year":"1988","unstructured":"Philip T, Hartmann O, Biron P, et al. (1988). High dose therapy and autologous bone marrow transplantation in partial remission after first line induction therapy for diffuse non Hodgkin\u2019s lymphoma. J Clin Oncol 6:1118\u20131124.","journal-title":"J Clin Oncol"},{"key":"7_CR23","first-page":"332a","volume":"82","author":"A Hagenbeek","year":"1993","unstructured":"Hagenbeek A, Verdonck L, Sonneveld P, Schouten H, van Imhoff G, van Putten W (1993). CHOP chemotherapy vs autologous BMT in slowly responding patients with intermediate and high grade malignant non Hodgkin\u2019s lymphoma: results from a prospective randomized phase III trial in 294 patients. Blood 82:332a (abstract).","journal-title":"Blood"},{"key":"7_CR24","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1200\/JCO.1988.6.12.1832","volume":"6","author":"A Surbone","year":"1988","unstructured":"Surbone A, Longo D, De Vita C Jr, et al. (1988). Residual masses in aggressive non Hodgkin\u2019s lymphoma after combination chemotherapy: signification and management. J Clin Oncol 6:1832\u20131837.","journal-title":"J Clin Oncol"},{"key":"7_CR25","first-page":"521","volume":"22","author":"O Cohen-Haguenauer","year":"1993","unstructured":"Cohen-Haguenauer O, Brice P, Gaci M, et al. (1993). Apport de la scintigraphie au gallium-67 dans les lymphomes malins. Presse Med 22:521\u2013525.","journal-title":"Presse Med"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","volume":"316","author":"T Philip","year":"1987","unstructured":"Philip T, Armitage O, Spitzer G, et al. (1987). High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high grade non Hodgkin\u2019s lymphoma. N Engl J Med 316:1493\u20131498.","journal-title":"N Engl J Med"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJM198406143102403","volume":"310","author":"GL Phillips","year":"1983","unstructured":"Phillips GL, Herzig RH, Lazarus HM, et al. (1983). Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. N Engl J Med 310:1557\u20131561.","journal-title":"N Engl J Med"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJM198706113162402","volume":"316","author":"T Takvorian","year":"1987","unstructured":"Takvorian T, Canellos GP, Ritz J, et al. (1987). Prolonged disease free survival after autologous bone marrow transplantation in patients with non Hodgkin\u2019s lymphoma with a poor prognosis. N Engl J Med 316:1499\u20131505.","journal-title":"N Engl J Med"},{"key":"7_CR29","first-page":"662","volume-title":"High Dose Cancer Therapy: Pharmacology Haematopoietins, Stem Cells","author":"AH Goldstone","year":"1992","unstructured":"Goldstone AH, MacMillan AK, Chopra R (1992). High dose therapy for the treatment of non Hodgkin\u2019s lymphoma. In Armitage JO, Antmann KA (eds), High Dose Cancer Therapy: Pharmacology Haematopoietins, Stem Cells. Baltimore: Williams and Wilkins, pp. 662\u2013670."},{"key":"7_CR30","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1200\/JCO.1992.10.10.1615","volume":"10","author":"A Bosly","year":"1992","unstructured":"Bosly A, Coiffier B, Gisselbrecht C, et al. (1992). Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. J Clin Oncol 10:1615\u20131623.","journal-title":"J Clin Oncol"},{"key":"7_CR31","first-page":"67a","volume":"80","author":"T Philip","year":"1992","unstructured":"Philip T, Guglielmi A, Hagenbeek A, et al. (1992). The Parma international randomized prospective study in relapsed non Hodgkin\u2019s lymphoma: second interim analysis of 172 patients. Blood 80:67a (abstract).","journal-title":"Blood"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/1097-0142(197803)41:3<1059::AID-CNCR2820410339>3.0.CO;2-N","volume":"41","author":"FR Appelbaum","year":"1987","unstructured":"Appelbaum FR, Deisseroth AB, Graw RG, et al. (1987). Prolonged complete remission following high dose chemotherapy of Burkitt\u2019s lymphoma in relapse. Cancer 41:1059\u20131063.","journal-title":"Cancer"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0308-2261(86)80012-1","volume":"15","author":"T Philip","year":"1986","unstructured":"Philip T, Pinkerton R, Hartmann O, et al. (1986). The role of massive therapy with autologous bone marrow transplantation in Burkitt\u2019s lymphoma. Clin Hematol 15:205\u2013218.","journal-title":"Clin Hematol"},{"key":"7_CR34","first-page":"677","volume-title":"High Dose Cancer Therapy: Pharmacology Haematopoietins, Stem Cells","author":"J-Y Blay","year":"1992","unstructured":"Blay J-Y, Philip T (1992). High dose therapy in Burkitt\u2019s lymphoma. In Armitage JO, Antmann KA (eds), High Dose Cancer Therapy: Pharmacology Haematopoietins, Stem Cells. Baltimore: Williams and Wilkins, pp. 677\u2013689."},{"key":"7_CR35","first-page":"340","volume":"11","author":"C Patte","year":"1992","unstructured":"Patte C, Michon J, Bouffet E, et al. (1992). High survival of childhood B-cell lymphoma and leukemia (ALL) as result of the LMB89 protocol of the SFOP. Proc Am Soc Clin Oncol 11:340 (abstract).","journal-title":"Proc Am Soc Clin Oncol"},{"key":"7_CR36","first-page":"317","volume":"12","author":"C Patte","year":"1993","unstructured":"Patte C, Leverger G, Rubie H, et al. (1993). High cure rate in B-cell (Burkitt\u2019s) leukemia in the LMB89 protocol of the SFOP. Proc Am Soc Clin Oncol 12:317 (abstract).","journal-title":"Proc Am Soc Clin Oncol"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/0959-8049(92)90235-T","volume":"28A","author":"T Philip","year":"1992","unstructured":"Philip T, Meckenstock R, Deconnick E, et al. (1992). Treatment of poor prognosis Burkitt\u2019s lymphoma in adults with the Societe Francaise d\u2019Oncologie Pediatrique LMB Protocol \u2014 a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC). Eur J Cancer 28A: 1954\u20131959.","journal-title":"Eur J Cancer"},{"key":"7_CR38","first-page":"389","volume":"34","author":"M Ostronoff","year":"1992","unstructured":"Ostronoff M, Soussain C, Zambon E, et al. (1992). Burkitt\u2019s lymphoma in adults: a retrospective study of 46 cases. Nouv Rev Fr Hematol 34:389\u2013397.","journal-title":"Nouv Rev Fr Hematol"},{"key":"7_CR39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","volume":"9","author":"C Patte","year":"1991","unstructured":"Patte C, Philip T, Rodary C, et al. (1991). High survival rate in advanced stage B cell lymphoma and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123\u2013132.","journal-title":"J Clin Oncol"},{"key":"7_CR40","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.V81.8.2003.2003","volume":"81","author":"T Philip","year":"1993","unstructured":"Philip T, Hartmann O, Pinkerton R, et al. (1993). Curability of relapsed childhood B-cell non-Hodgkin\u2019s lymphoma after intensive first line therapy: a report from the Societe Francaise d\u2019Oncologie Pediatrique. Blood 81:2003\u20132006.","journal-title":"Blood"},{"key":"7_CR41","first-page":"399","volume":"4","author":"CN Coleman","year":"1987","unstructured":"Coleman CN, Picozzi VJ, Cox RS, et al. (1987). Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 4:399\u2013404.","journal-title":"J Clin Oncol"},{"key":"7_CR42","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","volume":"10","author":"P Morel","year":"1992","unstructured":"Morel P, Lepage E, Brice P, et al. (1992). Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol 10:1078\u20131085.","journal-title":"J Clin Oncol"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2141.1989.tb00224.x","volume":"73","author":"N Milpied","year":"1989","unstructured":"Milpied N, Ifrah N, Kuentz M, et al. (1989). Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 73:82\u201387.","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"7_CR44","first-page":"42","volume":"5","author":"G Santini","year":"1991","unstructured":"Santini G, Congui AM, Coser P, et al. (1991). Autologous bone marrow transplantation for adult advanced stage adult non Hodgkin\u2019s lymphoma in first complete remission: a study of the NHLGSG. Leukemia 5(Suppl 1):42\u201345.","journal-title":"Leukemia"},{"key":"7_CR45","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","volume":"10","author":"LF Verdonck","year":"1992","unstructured":"Verdonck LF, Dekker AW, Gijsberg C, et al. (1992). Autologous bone marrow transplantation for adult poor risk lymphoblastic lymphoma in first remission. J Clin Oncol 10:644\u2013648.","journal-title":"J Clin Oncol"},{"key":"7_CR46","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","volume":"10","author":"R Chopra","year":"1992","unstructured":"Chopra R, Goldstone AH, Pearce R, et al. (1992). Autologous versus allogeneic bone marrow transplantation for non-Hodgkin\u2019s lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data. J Clin Oncol 10:1690\u20131695.","journal-title":"J Clin Oncol"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","volume":"311","author":"SJ Horning","year":"1984","unstructured":"Horning SJ, Rosenberg SA (1984). The natural history of initially untreated low grade lymphoma non Hodgkin\u2019s lymphoma. N Engl J Med 311:1471\u20131475.","journal-title":"N Engl J Med"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/bmj.1.6112.533","volume":"1","author":"TA Lister","year":"1978","unstructured":"Lister TA, Cullen MH, Beard MEJ, et al. (1978). Comparison of combined and single agent chemotherapy in non Hodgkin\u2019s lymphoma of favorable histological type. Br Med J 1:533\u2013537.","journal-title":"Br Med J"},{"key":"7_CR49","first-page":"11","volume":"25","author":"RC Young","year":"1988","unstructured":"Young RC, Longo DL, Glatstein E, et al. (1988). The treatment of indolent lymphoma: watchful waiting vs aggressive combined modality treatment. Semin Haematol 25:11\u201316.","journal-title":"Semin Haematol"},{"key":"7_CR50","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1200\/JCO.1987.5.6.867","volume":"5","author":"LP Mac","year":"1987","unstructured":"Mac Laughlin P, Fuller LM, Velasquez WS, et al. (1987). Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen. J Clin Oncol 5:867\u2013874.","journal-title":"J Clin Oncol"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1040-8428(86)80024-5","volume":"5","author":"LA Matis","year":"1986","unstructured":"Matis LA, Young RS, Longo DL (1986). Nodular lymphoma: current concepts. CRC Crit Rev Oncol Hematol 5:171\u2013181.","journal-title":"CRC Crit Rev Oncol Hematol"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJM199211053271902","volume":"327","author":"RV Smalley","year":"1992","unstructured":"Smalley RV, Andersen JW, Hawkins MJ, et al. (1992). Interferon alfa combined with cyto-toxic chemotherapy for patients with non-Hodgkin\u2019s lymphoma. N Engl J Med 327:1336\u20131341.","journal-title":"N Engl J Med"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJM199312093292419","volume":"329","author":"JW Andersen","year":"1993","unstructured":"Andersen JW, Smalley RV (1993). Interferon alfa plus chemotherapy for non-Hodgkin\u2019s lymphoma: five-year follow-up. N Engl J Med 329:1821\u20131822 (letter).","journal-title":"N Engl J Med"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJM199311253292203","volume":"329","author":"P Solal-Celigny","year":"1993","unstructured":"Solal-Celigny P, Lepage E, Brousse N, et al. (1993). Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. N Engl J Med 329:1608\u20131614.","journal-title":"N Engl J Med"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","volume":"325","author":"JG Gribben","year":"1991","unstructured":"Gribben JG, Freedman AS, Neuberg D, et al. (1991). Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525\u20131533.","journal-title":"N Engl J Med"},{"key":"7_CR56","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V78.12.3275.3275","volume":"78","author":"JG Gribben","year":"1991","unstructured":"Gribben JG, Freedman AS, Woo SD, et al. (1991). All advanced stage non-Hodgkin\u2019s lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275\u20133280.","journal-title":"Blood"},{"key":"7_CR57","first-page":"369","volume":"12","author":"N Berinstein","year":"1992","unstructured":"Berinstein N, Reis MD, Ngan BY, et al. (1992). Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early and advanced stage follicular lymphoma. Proc Am Soc Clin Oncol 12:369 (abstract).","journal-title":"Proc Am Soc Clin Oncol"},{"key":"7_CR58","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1182\/blood.V77.11.2524.2524","volume":"77","author":"AS Freedman","year":"1991","unstructured":"Freedman AS, Ritz J, Neuberg D, et al. (1991). Autologous bone marrow transplantation in 69 patients with a history of low grade B cell non Hodgkin\u2019s lymphoma. Blood 77:2524\u20132529.","journal-title":"Blood"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","volume":"341","author":"MK Brenner","year":"1993","unstructured":"Brenner MK, Rill DR, Moen RC, et al. (1993). Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85\u201386.","journal-title":"Lancet"},{"key":"7_CR60","first-page":"317","volume":"11","author":"P Bierman","year":"1992","unstructured":"Bierman P, Vose J, Armitage JO, et al. (1992). High dose chemotherapy followed by autologous hematopoietic rescue for follicular low grade lymphoma. Proc Am Soc Clin Oncol 11:317 (abstract).","journal-title":"Proc Am Soc Clin Oncol"},{"key":"7_CR61","first-page":"33","volume":"2","author":"A Freedman","year":"1992","unstructured":"Freedman A, Nadler LM (1992). Bone marrow transplantation in low grade non Hodgkin\u2019s lymphoma. Marrow Transplant Rev 2:33\u201338.","journal-title":"Marrow Transplant Rev"},{"key":"7_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1600-0609.1991.tb01539.x","volume":"46","author":"L Fouillard","year":"1991","unstructured":"Fouillard L, Gorin NC, Laporte JP, et al. (1991). Feasibility of autologous bone marrow transplantation for early consolidation of follicular non-Hodgkin\u2019s lymphoma. Eur J Haematol 46:279\u2013284.","journal-title":"Eur J Haematol"},{"issue":"Suppl 2","key":"7_CR63","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1093\/annonc\/5.suppl_2.S147","volume":"5","author":"HC Schouten","year":"1994","unstructured":"Schouten HC, Colombat P, Verdonck P, et al. (1994). Autologous bone marrow transplantation for low grade lymphoma: the European Bone Marrow Transplant Group experience. Ann Oncol 5(Suppl 2):S147\u2013S150.","journal-title":"Ann Oncol"},{"key":"7_CR64","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.1992.10.6.942","volume":"10","author":"DJ Weisdorf","year":"1992","unstructured":"Weisdorf DJ, Anerson JW, Glick JH, et al. (1992). Survival after relapse of low grade non Hodgkin\u2019s lymphoma: implication for bone marrow transplantation. J Clin Oncol 10:942\u2013947.","journal-title":"J Clin Oncol"},{"key":"7_CR65","first-page":"465","volume-title":"Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium","author":"AZS Rohatiner","year":"1990","unstructured":"Rohatiner AZS, Price CGA, Arnott S, et al. (1990). Ablative therapy with autologous bone marrow transplantation as consolidation of remission in patients with follicular lymphoma. In Dicke KA, Armitage JO, Discke-Evinger MJ (eds), Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium. Omaha: University of Nebraska Medical Center, pp. 465\u2013470."},{"issue":"Suppl 2","key":"7_CR66","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1093\/annonc\/5.suppl_2.S143","volume":"5","author":"AZS Rohatiner","year":"1994","unstructured":"Rohatiner AZS, Freedman A, Nadler L, et al. (1994). Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma. Ann Oncol 5(Suppl 2):S143\u2013S146.","journal-title":"Ann Oncol"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/10428199209061555","volume":"7","author":"P Colombat","year":"1992","unstructured":"Colombat P, Binet C, Linassier C, et al. (1992). High dose chemotherapy with autologous marrow transplantation in follicular lymphomas. Leuk Lymphoma 7:3\u20136.","journal-title":"Leuk Lymphoma"},{"key":"7_CR68","first-page":"1255","volume":"13","author":"Y Bastion","year":"1994","unstructured":"Bastion Y, Brice P, Sonet A, et al. (1994). Autologous peripheral blood stem cell transplantation (PBSCT) in 40 patients with advanced follicular lymphoma. Proc Am Soc Clin Oncol 13:1255 (abstract).","journal-title":"Proc Am Soc Clin Oncol"},{"key":"7_CR69","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.1991.9.10.1848","volume":"9","author":"JH Lungren","year":"1991","unstructured":"Lungren JH, Hansen RM, Chitambar CR, et al. (1991). Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA identical and alternative donors. J Clin Oncol 9:1848\u20131859.","journal-title":"J Clin Oncol"},{"key":"7_CR70","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","volume":"77","author":"RJ Jones","year":"1991","unstructured":"Jones RJ, Ambinder RF, Piantadosi S, Santos GW (1991). Evidence of a graft versus lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77:649\u2013653.","journal-title":"Blood"},{"key":"7_CR71","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1987.5.9.1340","volume":"5","author":"FR Appelbaum","year":"1987","unstructured":"Appelbaum FR, Sullivan KM, Buckner CD, et al. (1987). Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation and marrow transplantation. J CLin Oncol 5:1340\u20131347.","journal-title":"J CLin Oncol"},{"key":"7_CR72","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1200\/JCO.1986.4.4.480","volume":"4","author":"GL Phillips","year":"1986","unstructured":"Phillips GL, Herzig RH, Lazarus HM, et al. (1986). High dose chemotherapy, fractionated total body irradiation, and allogeneic marrow transplantation for malignant lymphoma. J Clin Oncol 4:480\u2013488.","journal-title":"J Clin Oncol"},{"key":"7_CR73","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1182\/blood.V78.12.3306.3306","volume":"78","author":"HG Klingemann","year":"1991","unstructured":"Klingemann HG, Grigg A, Wilkie-Boyd K, et al. (1991). Treatment with recombinant interferon alpha ealry after bone marrow transplantation in patients at high risk for relapse. Blood 78:3306\u20133311.","journal-title":"Blood"},{"key":"7_CR74","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood.V74.7.2335.2335","volume":"74","author":"DJ Gottlieb","year":"1989","unstructured":"Gottlieb DJ, Prentice HG, Geslop HE, et al. (1989). Effects of recombinant IL-2 administration on cytotoxic function following high dose chemo-radiotherapy for hematological malignancy. Blood 74:2335\u20132342.","journal-title":"Blood"},{"key":"7_CR75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1200\/JCO.1994.12.2.249","volume":"12","author":"MJ Kennedy","year":"1994","unstructured":"Kennedy MJ, Vogelsang GB, Jones RJ, et al. (1994). Phase I trial of interferon gamma to potentiate cyclosporine induced graft versus host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 12:249\u2013257.","journal-title":"J Clin Oncol"},{"key":"7_CR76","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1182\/blood.V74.4.1260.1260","volume":"74","author":"A Kessinger","year":"1989","unstructured":"Kessinger A, Armitage JO, Smith DM, et al. (1989). High dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74:1260\u20131265.","journal-title":"Blood"},{"key":"7_CR77","first-page":"337","volume":"9","author":"P Brice","year":"1992","unstructured":"Brice P, Marolleau JP, Dombret H, et al. (1992). Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas. Bone Marrow Transplant 9:337\u2013342.","journal-title":"Bone Marrow Transplant"},{"key":"7_CR78","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1200\/JCO.1993.11.10.1846","volume":"11","author":"JM Vose","year":"1993","unstructured":"Vose JM, Anderson JR, Kessinger A, et al. (1993). High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 11:1846\u20131851.","journal-title":"J Clin Oncol"},{"issue":"S2","key":"7_CR79","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1093\/annonc\/5.suppl_2.S151","volume":"5","author":"G Liberti","year":"1994","unstructured":"Liberti G, Pearce R, Taghipour G, Majolino I, Goldstone AH (1994). Comparison of peripheral blood stem cell and autologous bone marrow transplantation for lymphoma patients: a case control analysis of the EBMT registry data. Ann Oncol 5(S2):S151\u2013S153.","journal-title":"Ann Oncol"},{"key":"7_CR80","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/scd.1.1992.1.317","volume":"1","author":"LS Schwartzenberg","year":"1992","unstructured":"Schwartzenberg LS, Birch R, Haselton B, et al. (1992). Peripheral blood stem cell mobilisation by chemotherapy with and without rG-CSF J Haematother 1:317\u2013327.","journal-title":"J Haematother"},{"key":"7_CR81","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/0140-6736(92)90795-5","volume":"339","author":"WP Sheridan","year":"1992","unstructured":"Sheridan WP, Begley CG, Juttner CA, et al. (1992). Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640\u2013644.","journal-title":"Lancet"},{"key":"7_CR82","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM199106203242504","volume":"324","author":"J Nemunaitis","year":"1991","unstructured":"Nemunaitis J, Rabinowe SN, Singer JW, et al. (1991). Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324:1773\u20131778.","journal-title":"N Engl J Med"},{"key":"7_CR83","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1182\/blood.V80.5.1149.1149","volume":"80","author":"N-C Gorin","year":"1992","unstructured":"Gorin N-C, Coiffier B, Hayat M, et al. (1992). Recombinant human GM-CSF after high dose chemotherapy and autologous bone marrow transplantation with unpurged and pruged marrow in non Hodgkin\u2019s lymphoma. Blood 80:1149\u20131157.","journal-title":"Blood"},{"key":"7_CR84","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0140-6736(94)91579-2","volume":"343","author":"C Gisselbrecht","year":"1994","unstructured":"Gisselbrecht C, Prentice HG, Bacigalupo A, Biron P, Milpied N, Rubie H, Cunningham D, Legros M, Pico JL, Linch DC, Burnett AK, Scarffe JH, Siegert W, Yver A (1994). Placebo controlled phase III trial of lenograstim in bone marrow transplantation. Lancet 343:696\u2013700.","journal-title":"Lancet"},{"key":"7_CR85","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.1994.12.4.661","volume":"12","author":"G Spitzer","year":"1994","unstructured":"Spitzer G, Adkins DR, Spencer V, et al. (1994). Randomized study of growth factors post-peripheral blood stem cell transplant: neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 12:661\u2013670.","journal-title":"J Clin Oncol"}],"container-title":["Cancer Treatment and Research","Advances in Lymphoma Research"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-4129-5_7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T06:30:17Z","timestamp":1605681017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-4129-5_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"ISBN":["9781461368519","9781461541295"],"references-count":85,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-4129-5_7","relation":{},"ISSN":["0927-3042"],"issn-type":[{"type":"print","value":"0927-3042"}],"subject":[],"published":{"date-parts":[[1997]]}}}